ProfileGDS4459 / ENSG00000147419
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 94% 94% 91% 95% 95% 94% 95% 93% 95% 93% 95% 94% 92% 94% 92% 94% 95% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 17.9494
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 27.9294
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.5191
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 47.9895
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 58.3995
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 67.9794
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.1195
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 87.8293
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 98.1695
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.7793
GSM623474group B, liver allograft wedge biopsie placebo treatment 18.3995
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.1794
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.5992
GSM623477group B, liver allograft wedge biopsie placebo treatment 47.9894
GSM623478group B, liver allograft wedge biopsie placebo treatment 57.7792
GSM623479group B, liver allograft wedge biopsie placebo treatment 67.9794
GSM623480group B, liver allograft wedge biopsie placebo treatment 78.1595